An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat

British Journal of Pharmacology

Volumn 117, Issue 1, 1996, Pages 196-202

  Ren, K ^a,b   Iadarola, M J ^a   Dubner, R ^a,b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

CP 96,345; Dextrorphan; Hyperalgesia; Isobologram; NK1 tachykinin receptor antagonists; NMDA receptor antagonist; Tachykinin receptors; WIN 51,708

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; DEXTRORPHAN; FREUND ADJUVANT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST;

ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; INTRATHECAL DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; WITHDRAWAL REFLEX;

EID: 0030031674     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15174.x     Document Type: Article

References (63)

1. AANONSEN, L.M. & WILCOX, G.L. (1986). Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Neurosci. Lett., 67, 191-197.
2. AANONSEN, L.M. & WILCOX, G.L. (1987). Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J. Pharmacol. Exp. Ther., 243, 9-19.
3. ADAMS, J.U., TALLARIDA, R.J., GELLER, E.B. & ADLER, M.W. (1993). Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J. Pharmacol. Exp. Ther., 266, 1261-1267.
4. APELL, K.C. FRAGALE, B.J., LOSCIG, J., SINGH, S. & TOMCZUK, B.E. (1992). Antagonists that demonstrate species differences in neurokinin-1 receptors. Mol. Pharmacol., 41, 772-778.
5. BATTAGLIA, G. & RUSTIONI, A. (1988). Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J. Com. Neurol., 277, 302-312.
6. 1 receptors by use of the non-peptide antagonist, CP-96,345. Br. J. Pharmacol., 104, 292-293.
7. 1 receptor antagonist, (±)-CP-96,345, produces antinociceptive and anti-oedema effects in the rat. Br. J. Pharmacol., 105, 508-510.
8. CAUDLE, R.M. & WILLIAMS, G.M. (1993). The misuse of analysis of variance to detect synergy in combination drug studies. Pain, 55, 313-317.
9. CHAPMAN, V. & DICKENSON, A.H. (1993). The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord. Neurosci. Lett., 157, 149-152.
10. CHURCH, J., LODGE, D. & BERRY, S.C. (1985). Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur. J. Pharmacol., 111, 185-190.
11. CODERRE, T.J. & MELZACK, R. (1991). Central neural mediators of secondary hyperalgesia following heat injury in rats: neuropeptides and excitatory amino acids. Neurosci. Lett., 131, 71-74.
12. DE BIASI, S. & RUSTIONI, A. (1988). Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc. Natl. Acad. Sci. U.S.A., 85, 7820-7824.
13. DE KONINCK, Y. & HENRY, J.L. (1991). Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation. Proc. Natl. Acad. Sci. U.S.A., 88, 11344-11348.
14. DOUGHERTY, P.M. & WILLIS, W.D. (1991). Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain, 47, 85-93.
15. GARCES, Y.I., RABITO, S.F., MINSHALL, R.D. & SAGEN, J. (1992). Lack of potent antinociceptive activity by substance P antagonist CP-96,345 in the rat spinal cord. Life Sci., 52, 353-360.
16. GARRET, C., CARRUETTE, A., FARDIN, V., MOUSSAOUI, S., PEYRONNEL, J.-F., BLANCHARD, J.-C. & LADURON, P.M. (1991). Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. U.S.A., 88, 10208-10212.
17. 1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences. Br. J. Pharmacol., 110, 385-391.
18. HALEY, J.E., SULLIVAN, A.F. & DICKENSON, A.H. (1990). Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res., 518, 218-226.
19. HARGREAVES, K., DUBNER, R., BROWN, F., FLORES, C. & JORIS, J. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
20. HENLEY, J.M., JENKINS, R. & HUNT, S.P. (1993). Localisation of glutamate receptor binding sites and mRNAs to the dorsal horn of the rat spinal cord. Neuropharmacol., 32, 37-41.
21. HERSHEY, A.D. & KRAUSE, J.E. (1990). Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science, 247, 958-962.
22. HYLDEN, J.L.K., NAHIN, R.L., TRAUB, R.J. & DUBNER, R. (1989). Expansion of receptive fields of spinal lamina I projection neurons in rats with unilateral adjuvant-induced inflammation: the contribution of dorsal horn mechanisms. Pain, 37, 229-243.
23. HYLDEN, J.L.K., THOMAS, D.A., IADAROLA, M.J., NAHIN, R.L. & DUBNER, R. (1991). Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol., 194, 135-143.
24. HYLDEN, J.L.K., & WILCOX, G.L. (1983). Pharmacological characterization of substance P-induced nociception in mice: Modulation by opioid and noradrenergic agonists at the spinal level. J. Pharmacol. Exp. Ther., 226, 398-404.
25. IADAROLA, M.J., BRADY, L.S., DRAISCI, G. & DUBNER, R. (1988). Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain, 35, 313-326.
26. IADAROLA, M.J. & DRAISCI, G. (1988). Elevation of spinal cord dynorphin mRNA compared to dorsal root ganglion peptide mRNAs during peripheral inflammation. In The Arthritic Rat as a Model of Clinical Pain? ed. Besson, J.M. & Guilbaud, G. pp. 173-183. Amsterdam: Elsevier.
27. MAO, J., PRICE, D.D., HAYES, R.L., LU, J., MAYER, D.J. & FRENK, H. (1993). Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res., 605, 164-168.
28. MCCARSON, K.E. & KRAUSE, J.E. (1994). NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J. Neurosci., 14, 712-720.
29. MENDELSOHN, L.G., KERCHNER, G.A., KALRA, V., ZIMMERMAN, D.M. & LEANDER, J.D. (1984). Phencyclidine receptors in rat brain cortex. Biochem. Pharmacol., 33, 3529-3535.
30. MINAMI, M., KURAISHI, Y., KAWAMURA, M., YAMAGUCHI, T., MASU, Y., NAKANISHI, S. & SATOH, M. (1989). Enhancement of preprotachykinin A gene expression by adjuvant-induced inflammation in the rat spinal cord: possible involvement of substance P-containing spinal neurons in nociception. Neurosci. Lett., 98, 105-110.
31. MJELLEM-JOLY, N., LUND, A., BERGE, O-G. & HOLE, K. (1991). Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acid agonists. Neurosci. Lett., 133, 121-124.
32. MJELLEM-JOLY, N., LUND, A., BERGE, O-G. & HOLE, K. (1992). Intrathecal co-administration of substance P and NMDA augments nociceptive responses in the formalin test. Pain, 51, 195-198.
33. NAGAHISA, A., ASAI, R., KANAI, Y., MURASE, A., TSUCHIYA-NAKAGAKI, M., NAKAGAKI, T., SHIEH, T-C. & TANIGUCHI, K. (1992a). Non-specific activity of (±)-CP-96,345 in models of pain and inflammation. Br. J. Pharmacol., 107, 273-275.
34. NAGAHISA, A., KANAI, Y., SUGA, O., TANIGUCHI, K., TSUCHIYA, M., LOWE III, J.A. & HESS, H-J. (1992b). Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist. Eur. J. Pharmacol., 217, 191-195.
35. NEUGEBAUER, V., WEIRETTER, F. & SCHAIBLE, H-G. (1995). Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J. Neurophysiol., 73, 1574-1583.
36. NOGUCHI, K. & RUDA, M.A. (1992). Gene regulation in an ascending nociceptive pathway: inflammation-induced increase in prepro tachykinin mRNA in rat lamina I spinal projection neurons. J. Neurosci., 12, 2563-2572.
37. OSSIPOV, M.H., HARRIS, S., LLOYD, P. & MESSINEO, E. (1990). An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. J. Pharmacol. Exp. Ther., 255, 1107-1116.
38. PRICE, D.D., MAO, J., FRENK, H. & MAYER, D.J. (1994). The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain, 59, 165-174.
39. RADHAKRISHNAN, V. & HENRY, J.L. (1991). Novel substance P antagonist, CP-96,345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P. Neurosci. Lett., 132, 39-43.
40. RADHAKRISHNAN, V. & HENRY, J.L. (1995). Antagonism of nociceptive responses of cut spinal dorsal horn neurons in vivo by the NK-1 receptor antagonists CP-96,345 and CP-99,994, but not by CP-96,344. Neuroscience, 64, 943-958.
41. REN, K., HYLDEN, J.L.K., WILLIAMS, G.M., RUDA, M.A. & DUBNER, R. (1992a). The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain, 50, 331-344.
42. REN, K., WILLIAMS, G.M., HYLDEN, J.L.K., RUDA, M.A. & DUBNER, R. (1992b). The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. Eur. J. Pharmacol., 219, 235-243.
43. ROKKAS, C.K., HELFRICH, L.R., JR., LOBNER, D.C., CHOI, D.W. & KOUCHOUKOS, N.T. (1994). Dextrorphan inhibits the release of excitatory amino acids during spinal cord ischemia. Ann. Thorac. Surg., 58, 312-319.
44. 1 receptor antagonists: non-specific effects of racemic RPG7580. Br. J. Pharmacol., 110, 1607-1613.
45. RUSIN, K.I., BLEAKMAN, D., CHARD, P.S., RANDIC, M. & MILLER, R.J. (1993). Tachykinins potentiate N-methyl-D-aspartate responses in acutely isolated neurons from the dorsal horn. J. Neurochem., 60, 952-960.
46. SATOH, M., KURAISHI, Y. & KAWAMURA, M. (1992). Effects of intrathecal antibodies to substance P, calcitonin gene-related peptide and galanin on repeated cold stress-induced hyperalgesia: comparison with carrageenan-induced hyperalgesia. Pain, 49, 273-278.
47. SCHÄFER, M.K.-H., NOHR, D., KRAUSE, J.E. & WEIHE, E. (1993). Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurones. NeuroReport, 4, 1007-1010.
48. 2+ channels. Eur. J. Pharmacol., 215, 351-352.
49. SEGUIN, L. & MILLAN, M.J. (1994). The glycine B receptor partial agonist, (+)-HA966, enhances induction of antinociception by RP67580 and CP-99,994. Eur. J. Pharmacol., 253, R1-3.
50. SINGER, H.A., SPERK, G. & SCHMID, R. (1982). Capsaicin does not change tissue levels of glutamic acid, its uptake, or release in the rat spinal cord. J. Neurochem., 38, 1383-1386.
51. 1) receptor. Science, 251, 435-437.
52. SONG, X.-J. & ZHAO, Z.-O. (1994). Interaction between substance P and excitatory amino acid receptors in modulation of nociceptive responses of cat spinal dorsal horn neurons. Neurosci. Lett., 168, 49-52.
53. TAL, M. & BENNETT, G.J. (1993). Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neurosci. Lett., 151, 107-110.
54. TALLARIDA, R.J. (1992). Statistical analysis of drug combinations for synergism. Pain, 49, 93-97.
55. VENEPALLI, B.R., AIMONE, L.D., APPELL, K.C., BELL, M.R., DORITY, J.A., GOSWAMI, R., HALL, P.L., KUMAR, V., LAWRENCE, K.B., LOGAN, M.E., SCENSNY, P.M., SEELYE, J.A., TOMCZUK, B.E. & YANNI, J.M. (1992). Synthesis and substance P receptor binding activity of androstano[3,2-b]pyrimido[1,2-a]benzimidazoles. J. Med. Chem., 35, 374-378.
56. WANG, Z-Y., TUNG, S.R, STRICHARTZ, G.R. & HÅKANSON, R. (1994). Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission. Br. J. Pharmacol., 111, 179-184.
57. XU, X.-J., DALSGAARD, C.-J. & WIESENFELD-HALLIN, Z. (1992). Spinal substance P and N-methyl-D-aspartate receptors are coactivated in the induction of central sensitization of the nociceptive flexor reflex. Neuroscience, 51, 641-648.
58. YAKSH, T.L. & RUDY, T.A. (1976). Chronic catheterization of the spinal subarachnoid space. Physiol. Behav., 17, 1031-1036.
59. YAMAMOTO, T., SHIMOYAMA, N. & MIZUGUCHI, T. (1993a). Effects of FK224, a novel cyclopeptide NK1 and NK2 antagonist, and CP-96,345, a nonpeptide NK1 antagonist, on development and maintenance of thermal hyperesthesia evoked by carrageenan injection in the rat paw. Anesthesiol., 79, 1042-1050.
60. YAMAMOTO, T., SHIMOYAMA, N. & MIZUGUCHI, T. (1993b). Effects of intrathecal FK888, a novel dipeptide NK1 receptor antagonist, on the formalin test in the rat. Neurosci. Lett., 161, 57-59.
61. YAMAMOTO, T. & YAKSH, T. (1991). Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci., 49, 1955-1963.
62. YASHPAL, K., RADHAKRISHNAN, V., CODERRE, T.J. & HENRY, J.L. (1993). CP-96,345, but not its stereoisomer, CP-96,344, blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience, 52, 1039-1047.
63. ZIMMERMANN, M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16, 109-110.